Boston Scientific (BSX) Financial Analysis & Valuation | Quarter Chart
Boston Scientific (BSX)
BSXPrice: $43.48
Fair Value: 🔒
🔒score
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and ... more
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various... more
Description
Shares
| Market Cap | $64.63B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | US | CEO | Michael F. Mahoney |
| IPO Date | 1992-05-19 | CAGR | 0.14% |
| Employees | 53,000 | Website | www.bostonscientific.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
BSX chart loading...
Fundamentals
Technicals
| Enterprise Value | $81.43B | P/E Ratio | 14.03 |
| Forward P/E | 11.69 | PEG Ratio | 0.18 |
| P/S Ratio | 2.36 | P/B Ratio | 1.88 |
| P/CF Ratio | 11.19 | P/FCF Ratio | 14.13 |
| EPS | $3.1 | EPS Growth 1Y | 74.38% |
| EPS Growth 3Y | 305.59% | EPS Growth 5Y | 2333.54% |
| Revenue Growth 1Y | 17.44% | Gross Margin | 0.7% |
| Operating Margin | 0.2% | Profit Margin | 0.17% |
| ROE | 0.15% | ROA | 0.08% |
| ROCE | 0.1% | Current Ratio | 1.9 |
| Quick Ratio | 1.22 | Cash Ratio | 0.33 |
| Debt/Equity | 0.43 | Interest Coverage | 11.62 |
| Altman Z Score | 3.22 | Piotroski Score | 7 |